Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study Comparing the Efficacy and Safety of Benzydamine Hydrochloride 0,3% Oromucosal Spray and Benzydamine Hydrochloride 3 mg Lozenges in Patients With Acute Sore Throat

NCT04941976 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT04941976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04941976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study Comparing the Efficacy and Safety of Benzydamine Hydrochloride 0,3% Oromucosal Spray and Benzydamine Hydrochloride 3 mg Lozenges in Patients With Acute Sore Throat
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Phase 4
Overall status
Completed
Start date
August 13, 2020
Completion date
June 30, 2021
Enrollment
356 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute sore throat